Valuation : CellaVision AB

Market Cap 3.92B 409M 352M 330M 301M 568M 39.05B 569M 1.53B 19.71B 1.53B 1.5B 65.36B P/E 2026 *
28.2x
P/E 2027 * 22.5x
Enterprise Value 3.73B 389M 335M 314M 287M 540M 37.18B 542M 1.45B 18.77B 1.46B 1.43B 62.23B EV / Sales 2026 *
4.81x
EV / Sales 2027 * 4.25x
Free-Float
81.06%
Yield 2026 *
1.67%
Yield 2027 * 1.91%
1 day-0.36%
1 week+0.37%
Current month+11.55%
1 month+10.65%
3 months+36.15%
6 months+11.55%
Current year+4.45%
1 week 163.6
Extreme 163.6
169.4
1 month 146.6
Extreme 146.6
170.4
Current year 117.6
Extreme 117.6
170.4
1 year 117.6
Extreme 117.6
192.2
3 years 117.6
Extreme 117.6
302
5 years 117.6
Extreme 117.6
476.4
10 years 70.75
Extreme 70.75
503.5
Manager TitleAgeSince
Chief Executive Officer - 05/06/2026
Director of Finance/CFO 46 02/09/2025
Investor Relations Contact - -
Director TitleAgeSince
Director/Board Member 61 -
Director/Board Member 62 04/05/2018
Chairman 64 29/04/2021
Date Insider Type Main position Quantity % Market Cap.
4/28/26 A Don

Founder

76,434 0.3205%
4/28/26 A Buy

Founder

20,000 0.0839%
4/28/26 A Buy

Founder

230,000 0.9643%
Change 5-day change 1-year change 3-year change Capi.($)
-0.36%+0.37%-5.74%-13.49% 409M
+1.24%+2.71%+27.90%-30.01% 18.18B
-0.71%+0.77%-35.40%+57.62% 1.65B
-3.79%0.00%-48.62%-82.20% 1.01B
+0.61%-3.00%-23.34%+19.49% 961M
+0.05%-0.05%+60.17%-6.23% 780M
-3.02%-2.34%-34.78%-47.87% 672M
+0.18%-0.11%-41.68%-52.05% 565M
+0.67%+1.77%-37.19%-34.81% 463M
-3.33%+0.47%+71.68%+42.50% 444M
Average -1.14%+1.71%-6.70%-14.70% 2.51B
Weighted average by Cap. -0.49%+2.68%+15.50%-23.25%

Financials

2026 *2027 *
Net sales 775M 80.86M 69.68M 65.33M 59.64M 112M 7.73B 113M 302M 3.9B 304M 297M 12.94B 870M 90.76M 78.21M 73.33M 66.94M 126M 8.67B 127M 339M 4.38B 341M 333M 14.52B
Net income 139M 14.5M 12.5M 11.72M 10.7M 20.15M 1.39B 20.21M 54.24M 700M 54.45M 53.27M 2.32B 174M 18.19M 15.68M 14.7M 13.42M 25.28M 1.74B 25.36M 68.04M 878M 68.3M 66.81M 2.91B
Net Debt -188M -19.56M -16.86M -15.8M -14.43M -27.18M -1.87B -27.26M -73.16M -944M -73.44M -71.85M -3.13B -222M -23.15M -19.95M -18.7M -17.07M -32.16M -2.21B -32.26M -86.57M -1.12B -86.91M -85.02M -3.7B
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
251
Date Price Change Volume
28/08/26 SEK 164.20 -0.36% 14,358
27/08/26 SEK 164.80 +0.49% 28,373
26/08/26 SEK 164.00 0.00% 11,993
25/08/26 SEK 164.00 -2.03% 25,988
24/08/26 SEK 167.40 +2.32% 35,410
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
164.20SEK
Average target price
175.67SEK
Spread / Average Target
+6.98%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CEVI Stock